Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -3.38 % |
3 Month Return | + 29.45 % |
1 Year Return | + 138.1 % |
Market Stats | |
Previous Close | ₹4.00 |
Open | ₹4.04 |
Volume | 29.10L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹750.93Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹750.93 Cr |
P/B Ratio | 1.28 |
EPS | 0.02 |
Dividend Yield | 0 |
Sector | Trading |
ROE | 1.26 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹750.93 Cr | -10.35% | 0.94 | ₹1 Cr | ₹56 Cr | |
NA | ₹454.34 Cr | 277.83% | 0.71 | NA | NA | |
NA | ₹112.37 Cr | 52.95% | 0.53 | ₹12 Cr | ₹487 Cr | |
NA | ₹21.57 Cr | -16.1% | 0.66 | NA | NA | |
NA | ₹21.85 Cr | 465.39% | 0.51 | NA | NA |
Organisation | Evexia Lifecare Ltd |
Headquarters | Ahmedabad |
Industry | Trading |
E-voting on shares | Click here to vote |
Key events for Evexia Lifecare Ltd
Evexia Lifecare shares rose 2% following a strong Q2 report, with sales up 150% and profit surging to Rs 6.9 crore. The company acquired a 65% stake in Diponed Bio and plans to invest Rs 200 million for expansion. Year-to-date, the stock has delivered a 110% return.
Evexia Lifecare Reports Strong Growth and Strategic Moves - 15 Nov, 2024
Evexia Lifecare reported a 250% jump in PAT for Q2FY25, with net sales increasing by 155%. The stock surged 1.78% to Rs 4. The company is also expanding its pharmaceutical business through strategic capital raises and a potential acquisition of a 65% stake in DIPOned Research.
Evexia Lifecare Issues Convertible Warrants to Promoters - 14 Nov, 2024
Evexia Lifecare's board approved the issuance of 24 crore convertible warrants at Rs 3.60 each, enhancing its capital structure. The company also plans to acquire a 65% stake in DIPOned Research International, aligning with its pharmaceutical expansion strategy.
Evexia Acquires Majority Stake in Diponed Bio - 11 Nov, 2024
Evexia Lifecare has announced its acquisition of a 65% stake in Diponed Bio Private Limited, purchasing 18,600 shares at Rs 10 each and investing INR 200 million for expansion.
Evexia Lifecare Expands Pharmaceutical Operations - 10 Nov, 2024
Evexia Lifecare is acquiring a 65% stake in DIPOned Research International to enhance its pharmaceutical activities. The company has also made significant investments in the UAE and plans to acquire a 51% stake in Vittals MediCare. With a market cap of Rs 790 crore and a 171.6% increase since its 52-week low, Evexia aims to strengthen its market position and deliver long-term value to shareholders.
Evexia Lifecare Expands Through Strategic Acquisitions - 09 Nov, 2024
Evexia Lifecare plans to acquire a 65% stake in Diponed Research International for Rs 15.18 crores, enhancing its pharmaceutical portfolio. The company also recently entered the UAE market and aims to acquire a stake in Vittals MediCare, indicating strong growth potential.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 1.03% to 1.49% in Sep 2024 quarter
Best in 1 Year
In the last 1 year, Evexia Lifecare has outperformed top 5 stocks with highest market-cap in Commodity Chemicals
Against Peers
In the last 3 years, Solar Industries India Ltd has given 256.4% return, outperforming this stock by 283.7%
Price Dip
In the last 3 years, Evexia Lifecare stock has moved down by -27.3%
Promoter Holding Down
Promoters have decreased holdings from 6.29% to 5.87% in Sep 2024 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 25.58 Cr → 21.36 Cr (in ₹), with an average decrease of 16.5% per quarter
Retail Holding Down
Retail Investor have decreased holdings from 92.50% to 92.47% in Sep 2024 quarter
Profit Down
Netprofit is down for the last 2 quarters, 2.73 Cr → 0.24 Cr (in ₹), with an average decrease of 91.2% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 5.87% | ||
Foreign Institutions | 1.49% | 45.48 | |
Mutual Funds | 0.04% | ||
Retail Investors | 92.47% | ||
Others | 0.13% |
Evexia Lifecare Ltd’s net profit jumped 9.09% since last year same period to ₹0.24Cr in the Q1 2024-2025. On a quarterly growth basis, Evexia Lifecare Ltd has generated -91.21% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Evexia Lifecare Ltd is currently in a Bearish trading position according to technical analysis indicators.
Evexia Lifecare Ltd (524444) share price today is ₹3.94
Evexia Lifecare Ltd is not listed on NSE
Evexia Lifecare Ltd is listed on BSE
Today’s traded volume of Evexia Lifecare Ltd(524444) is 29.10L.
Today’s market capitalisation of Evexia Lifecare Ltd(524444) is ₹750.93Cr.
Evexia Lifecare Ltd(524444 | Price |
---|---|
52 Week High | ₹4.4 |
52 Week Low | ₹1.55 |
Evexia Lifecare Ltd(524444) share price is ₹3.94. It is down -10.45% from its 52 Week High price of ₹4.4
Evexia Lifecare Ltd(524444) share price is ₹3.94. It is up 154.19% from its 52 Week Low price of ₹1.55
Evexia Lifecare Ltd(524444 | Returns |
---|---|
1 Day Returns | -0.06% |
1 Month Returns | -3.38% |
3 Month Returns | 29.45% |
1 Year Returns | 138.1% |